Skip to main content

Table 2 Sleep, Pain and Fatigue in SARS vs. FMS Subjects

From: Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study

Sleep Parameter

SARS (n = 22)

Fibromyalgia (n = 21)

Significance

 

Mean (SD)

Mean (SD)

 

Sleep onset latency ( min.)

24.13 (21.63)

18.37 (35.39)

n.s.

Total sleep time (min)

370.83 (83.84)

338.54 (76.26)

n.s.

Sleep Efficiency %

77.44 (13.56)

79.34 (15.63)

n.s.

Stage 1%

9.11 (4.13)

9.76 (3.66)

n.s.

Stage 2%

60.22 (9.95)

54.61(5.41)

0.031

Stage 3%

7.83 (6.36)

7.35 (3.08)

n.s.

Stage 4%

6.27 (5.80)

9.53 (6.18)

n.s.

REM onset Latency ( min.)

136.79 (63.72)

87.26 (35.78)

0.004

REM %

16.57 (5.94)

18.77 (4.81)

n.s.

Apnea/Hypopneas Index (no. per hr.of sleep)

4.70 (5.53)

3.29 (2.37)

n.s.

Periodic leg movements ( no.per hr of sleep)

2.03 (5.64)

2.38 (3.81)

n.s.

Arousals per hr of sleep

14.01 (7.59)

11.31 (5.31)

n.s.

CAP rate per hr of sleep

71.64 ()(14.25)

70.39 (15.64)

n.s.

Alpha EEG sleep (1-5)

3.00 (0.63)

3.50(0.61)

0.014

Presleep Pain Presleep Fatigue (1-7)

6.24 (4.01) 4.57 (1.57)

10.95 (5.74) 4.30 (1.08)

0.005 n.s.

Presleep Sleepiness (1-7)

2.76 (1.14)

4.30 (1.08)

0.0001

Post Sleep Pain (0-24)

7.10 (3.81)

11.75 (6.45)

0.009

Post Sleep Fatigue (1-7)

4.30 (1.87)

4.60 (1.23)

n.s.

Post Sleep Sleepiness (1-7)

3.45 (1.57)

3.90 (1.12)

n.s.